Abstract: Two novel lanostane-type triterpenes, Ganolactone B and Ganoderiol A triacetate, were isolated from the fruiting bodies of G. sinense, together with six known compounds. The structures of the two new triterpenes were determined as 3β,7β-dihydroxy-11,15-dioxo-lanosta-8-en-24→20 lactone (1) and 3β,24,26-triacetoxy-5α-lanosta-7,9(11)-dien-25-ol (2), respectively, by chemical and spectroscopic means.
Introduction
The fruiting body of the fungus Ganoderma lucidum Karst.(Polyporaceae) has attracted much attention as a well-known traditional Chinese medicine that has been used clinically in China, Japan, and Korea for a long time. Over the past recent two decades, more than 130 highly oxygenated lanostane-type triterpenoids have been isolated from the fruiting bodies, spores and culture mycelia of Ganoderma spp., including common fungal steroids derived from ergosterol. Some of them are known to possess varied bioactive properties. Other Ganoderma spp. have also been used in traditional Chinese, Japanese and Korean medicines, and their pharmacological activities as antitumor [1, 2] and antihypertensive agents [3] , their use in the treatment of chronic bronchitis and diabetes or their liver protective [4] , antioxidant [5] and anti-HIV activity [6] were studied. In this paper, we wish to report the structural elucidation by extensive spectroscopic analyses of two new components isolated together with known six compounds ( Figure 1 ) from the fruiting bodies of G. sinense. 
Results and Discussion
Dried chipped fruiting bodies of G. sinense were soaked overnight in acetone at room temperature to give an extract which was suspended in water and successively partitioned with petroleum ether, CHCl 3 , EtOAc and n-BuOH, respectively. The CHCl 3 layer was chromatographed on silica gel to separate it into six fractions. Some of these were subjected to silica gel column chromatography to give two new triterpene compounds, which we have named Ganolactone B (3β,7β-dihydroxy-11,15-dioxolanosta-8-en-24→20 lactone, 1), Ganoderiol A triacetate (3β,24,26-triacetoxy-5α-lanosta-7,9(11)-dien-25-ol, 2), together with six known compounds: Ganoderiol A (3) [7] , Ganodermatriol (4), Ganodermanontriol (5), 20(21)-dehydrolucidenic acid (6) [8] , Ganoderic acid D (7) [9] and Ganoderic acid A (8) [10] . . From these spectral data, the structure of this compound was established as 3β,24,26-triacetoxy-5α-lanosta-7, 9(11)-dien-25-ol, for which we propose the name Ganoderiol A triacetate. 
Experimental

General
Melting points were measured on a XRB-1 micro hot-stage melting point apparatus and are uncorrected. Optical rotations were measured with a DIP-370 automatic polarimeter. UV spectra were measured with a Shimadzu double-beam instrument. IR spectra were obtained on a Bio-Rad FTS-135 infrared spectrophotometer.
1 H-, 13 C-NMR and 2D-NMR spectra were recorded on a Bruker AM-400
MHz or a DRX-500 spectrometer with TMS as internal standard.
Plant Material
The fruiting bodies of G. sinenes were purchased from the Kunming natural medicine market, Yunnan Province, P. R. China in July 2005. The botanical identification was made by Prof. Yang Zhuliang (Kunming Institute of Botany, The Chinese Academy of Sciences).
Extraction and Isolation
Dried chipped fruiting bodies of G. sinense (8 kg) were soaked overnight in acetone at room temperature to afford an extract which was suspended in water and successively partitioned with petroleum ether (PE), CHCl 3 , EtOAc, and n-BuOH, respectively. The CHCl 3 extracts were concentrated in vacuo to afford a residue (115 g), which was subjected to silica gel column chromatography, using a CHCl 3 -Me 2 CO gradient (from 100% CHCl 3 to CHCl 3 -Me 2 CO 1:1) as eluent to separate it into six fractions (Fr. A -F). Fr. D (19.5 g) was subjected repeatedly to silica gel chromatography and eluted stepwise with PE-Me 2 CO (from 100% PE to PE-Me 2 CO 1:1) to afford compounds 2 (17 mg), 3 (29 mg), 4 (22 mg) and 5 (13 mg), respectively. Fr. E (8.3 g) was rechromatographed on a silica gel column chromatography by elution with PE-Me2CO (5:1 v/v, 3:1, 1:1) to yield 1 (36 mg). Fr. F (4.7g) was rechromatographed on a silica gel column chromatography by elution with PE-Me 2 CO (2:1 v/v, 1:2). Further purification of Fr. F-4 (1.7 g) was achieved by a reversed phase C-18 (from MeOH-H 2 O 40% to 65%) to give compounds 6 (12 mg), 7 (11 mg) and 8 (9 mg), respectively. 
